Nautilus Biotechnology

(NASDAQ) NAUT

Current Price$2.36

Market Cap$296.09M

Since IPO (2020)-78%

5 Year-76%

1 Year+235%

1 Month-8%

Nautilus Biotechnology Financials at a Glance

Market Cap

$296.09M

Revenue (TTM)

$0.00

Net Income (TTM)

-$57.09M

EPS (TTM)

-$0.45

P/E Ratio

-5.16

Dividend

$0.00

Beta (Volatility)

1.65 (High)

Dividend

$0.00

Beta (Volatility)

1.65 (High)

Price

$2.36

Volume

13,100

Open

$2.34

Price

$2.36

Volume

13,100

Open

$2.34

Previous Close

$2.36

Daily Range

$2.32 - $2.41

52-Week Range

$0.62 - $4.31

Estimated Earnings Date

Apr 28, 2026

Dividend

$0.00

Beta (Volatility)

1.65 (High)

Price

$2.36

Volume

13,100

Open

$2.34

Previous Close

$2.36

Daily Range

$2.32 - $2.41

52-Week Range

$0.62 - $4.31

Estimated Earnings Date

Apr 28, 2026

NAUT News

No articles available.

NAUT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nautilus Biotechnology

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

130

CEO

Sujal M. Patel

Website

www.nautilus.bio

Headquarters

Seattle, WA 98102, US

NAUT Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-35.04%

Return on Capital

-35.74%

Return on Assets

-32.11%

Earnings Yield

-19.38%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$296.09M

Shares Outstanding

127.08M

Volume

13.10K

Avg. Volume

396.35K

Financials (TTM)

Gross Profit

-$6.32M

Operating Income

-$64.12M

EBITDA

-$50.77M

Operating Cash Flow

-$49.86M

Capital Expenditure

-$1.57M

Free Cash Flow

-$51.43M

Cash & ST Invst.

$95.87M

Total Debt

$28.87M

Nautilus Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$1.48M

+9.2%

Gross Margin

0.00%

N/A

Market Cap

$296.09M

N/A

Market Cap/Employee

$2.28M

N/A

Employees

130

N/A

Net Income

-$14.70M

+11.5%

EBITDA

-$13.22M

+11.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$95.87M

-30.9%

Total Debt

$28.87M

-1.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$25.02M

-0.3%

Short Term Debt

$3.85M

-9.2%

Return on Assets

-32.11%

N/A

Return on Invested Capital

-37.84%

N/A

Free Cash Flow

-$13.61M

+3.9%

Operating Cash Flow

-$13.10M

+6.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ZURAZura Bio Limited

ZURAZura Bio Limited$4.26-1.05%

ENTAEnanta Pharmaceuticals, Inc.

ENTAEnanta Pharmaceuticals, Inc.$13.72-2.42%

FHTXFoghorn Therapeutics Inc.

FHTXFoghorn Therapeutics Inc.$4.08-1.45%

SGMTSagimet Biosciences Inc.

SGMTSagimet Biosciences Inc.$6.93-1.84%

ARCTArcturus Therapeutics Holdings Inc.

ARCTArcturus Therapeutics Holdings Inc.$7.01-0.99%

ASMBAssembly Biosciences, Inc.

ASMBAssembly Biosciences, Inc.$25.62-4.40%

IMRXImmuneering Corporation

IMRXImmuneering Corporation$4.60+1.32%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.44+0.08%

NOKNokia

NOKNokia$13.81+0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.87-0.04%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.27+0.01%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$154.54-0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.30-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.45+0.01%

Questions About NAUT

What is the current price of Nautilus Biotechnology?

Nautilus Biotechnology is trading at $2.36 per share.

What is the 52-week range for Nautilus Biotechnology?

Over the past 52 weeks, Nautilus Biotechnology has traded between $0.62 and $4.31.

How much debt does Nautilus Biotechnology have?

As of the most recent reporting period, Nautilus Biotechnology reported total debt of $28.87M.

How much cash does Nautilus Biotechnology have on hand?

Nautilus Biotechnology reported $14.63M in cash and cash equivalents in its most recent financial results.

What is Nautilus Biotechnology’s dividend yield?

Nautilus Biotechnology does not currently have a dividend yield.

Nautilus Biotechnology

Nautilus Biotechnology Financials at a Glance

NAUT News

NAUT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nautilus Biotechnology

NAUT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nautilus Biotechnology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NAUT

What is the current price of Nautilus Biotechnology?

What is the 52-week range for Nautilus Biotechnology?

How much debt does Nautilus Biotechnology have?

How much cash does Nautilus Biotechnology have on hand?

What is Nautilus Biotechnology’s dividend yield?

Premium Investing Services